Bladder Cancer: Clinical Trials

13 trials for Bladder Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 2 active not recruiting, 1 not yet recruiting, 1 terminated. 13 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 113Completed 9, Active not recruiting 2, Not yet recruiting 1, Terminated 1

Follow Bladder Cancer: new trials by email Literature Review of Bladder Cancer trials Research Report on Bladder Cancer

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bladder Preservation or Cystectomy for MIBC
Gemzar, Cisplatin, Adrucil - Muscle-Invasive Bladder Carcinoma, Bladder Cancer
Early Phase 1Active not recruitingDana-Farber Cancer Institute202026-09-022026-09-15
Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer
[64Cu]CM500, [68Ga]CM500, PET/MR - Bladder Cancer, Glioma
Early Phase 1Not yet recruitingLumina Pharmaceuticals Inc402026-09-012026-08-28
Assessment of Safety, Tolerability, Radiation Dosimetry, Imaging Properties of 89Zr-girentuximab in Patients With NMIBC
89Zr-TLX250 - Bladder Cancer
Early Phase 1CompletedInstitut Cancerologie de l'Ouest62021-12-152026-01-07
A Clinical Study of Recombinant Oncolytic Adenovirus L-IFN Injection With Multiple Administration Routes in Relapsed/Refractory Solid Tumors
Recombinant L-IFN adenovirus injection - Head and Neck Cancer, Melanoma
Early Phase 1CompletedShanghai Fengxian District Central Hospital252021-11-302026-11-16
18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy
18F-fluciclovine, PET/CT - Bladder Cancer, Urothelial Carcinoma
Early Phase 1CompletedBrigham and Women's Hospital162020-02-262026-06-24
(CLONEVO): Cell cycLe inhbitiON to Target the EVolution of UrOthelial Cancer
Abemaciclib - Bladder Cancer
Early Phase 1Active not recruitingWeill Medical College of Cornell University202019-02-052026-10-26
A Superiority Trial to Compare Re-resection of High-grade T1 Bladder Urothelial Carcinoma to no Re-resection for Improving Progression Free Survival
re-TURBT, 6 weeks BCG instillation - Bladder Cancer, Bladder Urothelial Carcinoma
Early Phase 1TerminatedUniversity Health Network, Toronto22017-11-162022-04-20
A Study of Rapamycin Combined With Intravesical BCG in Patients With Non-muscle Invasive Bladder Cancer
Sirolimus - Bladder Cancer
Early Phase 1CompletedThe University of Texas Health Science Center at San Antonio332016-06-012021-03-19
PRIME: Pilot Study Evaluating Percutaneous Vaccination of BCG for Bladder Cancer
Bacillus Calmette-Guerin (BCG) - Bladder Cancer
Early Phase 1CompletedThe University of Texas Health Science Center at San Antonio252013-10-012017-01-25
Impact Advanced Recovery® for Radical Cystectomy (RC) Patients: a Pilot Study
Boost Plus®, Impact Advanced Recovery® - Bladder Cancer, Radical Cystectomy
Early Phase 1CompletedJill Hamilton-Reeves, PhD RD LD302013-07-012026-04-15
BLADDER CANCER SCREENING AMONG DIABETIC PATIENTS
metformin - Bladder Cancer, Diabetes
Early Phase 1CompletedUFUOMA MILLER FAKPOR1502013-06-012015-07-22
Impact of Valproate on Angiogenesis and Histone Deacetylation in Bladder Cancer
Valproic Acid - Hematuria, Bladder Cancer
Early Phase 1CompletedState University of New York - Upstate Medical University432011-12-012021-10-22
Study of BCG + Aminophylline Toxicity When Used in the Treatment of Bladder Cancer
aminophylline - Bladder Cancer
Early Phase 1CompletedUniversity of Virginia32010-07-012014-04-14

Narrower conditions

Urinary Bladder Neoplasms (13)  ·  Carcinoma, Transitional Cell (3)  ·  Breast Neoplasms (2)  ·  Lung Neoplasms (2)  ·  Ovarian Neoplasms (2)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Colorectal Neoplasms (1)  ·  Diabetes Mellitus (1)  ·  Esophageal Neoplasms (1)  ·  Glioblastoma (1)  ·  Glioma (1)  ·  Head and Neck Neoplasms (1)  ·  Hematuria (1)  ·  Kidney Neoplasms (1)  ·  Liver Neoplasms (1)

Broader conditions

Female Urogenital Diseases (13)  ·  Female Urogenital Diseases and Pregnancy Complications (13)  ·  Male Urogenital Diseases (13)  ·  Neoplasms by Site (13)  ·  Urinary Bladder Diseases (13)  ·  Urogenital Diseases (13)  ·  Urogenital Neoplasms (13)  ·  Urologic Diseases (13)  ·  Urologic Neoplasms (13)  ·  Neoplasms (12)  ·  Neoplasms by Histologic Type (6)  ·  Neoplasms, Glandular and Epithelial (5)  ·  Carcinoma (4)  ·  Endocrine System Diseases (3)  ·  Adnexal Diseases (2)

Interventions

Positron Emission Tomography Computed Tomography (2)  ·  Aminophylline (1)  ·  BCG Vaccine (1)  ·  Blood Specimen Collection (1)  ·  Cisplatin (1)  ·  Cystectomy (1)  ·  Fluorouracil (1)  ·  Gemcitabine (1)  ·  Metformin (1)  ·  Mitomycin (1)  ·  Oncolytic Virotherapy (1)  ·  Sirolimus (1)  ·  Valproic Acid (1)  ·  abemaciclib (1)  ·  fluciclovine F-18 (1)

Sponsors

The University of Texas Health Science Center at San Antonio (2)  ·  Brigham and Women's Hospital (1)  ·  Dana-Farber Cancer Institute (1)  ·  Institut Cancerologie de l'Ouest (1)  ·  Jill Hamilton-Reeves, PhD RD LD (1)  ·  Lumina Pharmaceuticals Inc (1)  ·  Shanghai Fengxian District Central Hospital (1)  ·  State University of New York - Upstate Medical University (1)  ·  UFUOMA MILLER FAKPOR (1)  ·  University Health Network, Toronto (1)  ·  University of Virginia (1)  ·  Weill Medical College of Cornell University (1)

Countries

United States (9)  ·  Canada (1)  ·  China (1)  ·  France (1)  ·  Ghana (1)

Top investigators

Bishoy Faltas, MD (1)  ·  Charlene Mantia, MD (1)  ·  Feng Liu, PhD (1)  ·  Girish Kulkarni, MD PhD FRCSC (1)  ·  Heather Jacene, MD (1)  ·  Jill Hamilton-Reeves, PhD, RD, LD (1)  ·  Oleg Shapiro, MD (1)  ·  Robert S Svatek, MD (1)  ·  Robert Svatek, MD (1)  ·  Tracy L Krupski, M.D. (1)

Results publications

PMID 26654125, PMID 33653802, PMID 38719544

NIH funding

R44CA275590 (1)